Brilliant StarsBrilliant Stars🃏All Clefairy cards
Ask about Clefairy
Clefairy #53 Pokémon card from Brilliant Stars

Clefairy 53/172

Brilliant Stars

Find this card on eBay

Affiliate link · we may earn commission

Clefairy #53 from Brilliant Stars currently trades at $0.66 raw, with PSA 10 copies reaching $32.52 — a 49.3x grade premium.
Current Prices (USD)
Ungraded
$0.66
PSA 7
$11.38
PSA 8
$11.38
PSA 9
$11.38
PSA 10
$32.52
ACE 10
BGS 10 Black
$210.00
CGC 10 Pristine
$21.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Clefairy 53/172 from Brilliant Stars has a current raw market value of $0.66.

Current raw value
$0.66
PSA 9 value
$11.38
PSA 10 value
$32.52
PSA 10 premium vs raw
49.3× raw
View all cards from Brilliant Stars
Collector Intel
49.3x
Raw → PSA 10
High-risk grade
17.2x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 49x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$33
PSA 10 Value
+$7
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1117.2x raw
PSA 10$3349.3x raw

Frequently asked questions

How much is Clefairy #53 from Brilliant Stars worth?+
Clefairy #53 from Brilliant Stars is currently worth Raw: $0.66, PSA 9: $11.38, PSA 10: $32.52 based on recent sold listings. Prices update daily from real eBay sales.
Is Clefairy #53 worth grading?+
The PSA 10 price of $32.52 is 49.3× the raw price of $0.66. After a ~$25 grading fee, a PSA 10 result would net approximately $31.86 — assuming the card grades a 10.
Where do PokePrices Clefairy #53 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.